Yat Yin Lam - Concepedia

Author

Yat Yin Lam

Chinese University of Hong Kong

Also Known As

Andy Lam, Michael J. Mirro, YAT Y. LAM, Yat Lam, Yat Yin LAM, Yat Yin Lam

Publications

993

Citations

H-Index

Concepts

All Affiliations

Chinese University of Hong Kong Prince of Wales Hospital Erciyes University

About

Yat Yin Lam is an author at Chinese University of Hong Kong specializing in cardiovascular disease, medicine, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	772
2	Public Health	5	5	457
3	Emergency Medicine	3	3	383
4	Epidemiology	3	3	398
5	Biostatistics	1	1	37

Yat Yin Lam

Publications

932

Citations

H-Index

Page 1

	Year	Citations
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study Mehmet Güngör Kaya, Metin Özkan, Özgür Günebakmaz, International Journal of Cardiology CardiomyopathyHeart FailureCardiovascular DiseaseAnthracycline-induced CardiomyopathyPharmacology	2012	315
Relation of Neutrophil/Lymphocyte Ratio to Coronary Flow to In-Hospital Major Adverse Cardiac Events in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention Mahmut Akpek, Mehmet Güngör Kaya, Yat Yin Lam, The American Journal of Cardiology ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseHematologyCoronary Flow	2012	234
Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: A prospective, multicenter study Mehmet Güngör Kaya, Mahmut Akpek, Yat Yin Lam, International Journal of Cardiology Primary Coronary InterventionThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseSt-elevated Myocardial Infarction	2012	127
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry Giulio Francesco Romiti, Bernadette Corica, Marco Proietti, EClinicalMedicine	2023	38
Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong Jason Ho, Andy Chang, Bryan P. Yan, Clinical Cardiology PharmacotherapyThrombosisClinical EpidemiologyClinical TrialsHong Kong	2012	37
Relation Between Serum Total Bilirubin Levels and Severity of Coronary Artery Disease in Patients With Non-ST-Segment Elevation Myocardial Infarction Mehmet Güngör Kaya, Ömer Şahin, Mahmut Akpek, Angiology Cardiometabolic RiskLogistic AnalysisCoronary Artery DiseaseAcute Myocardial InfarctionConsecutive Patients	2013	37
Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong Vivian Lee, Cheuk Shing Tam, Bryan P. Yan, Clinical Cardiology	2012	36
Cost‐Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Patients With Atrial Fibrillation—A Real Patient Data Analysis in a Hong Kong Teaching Hospital Andy Chang, Jason Ho, Bryan P. Yan, Clinical Cardiology	2013	22
Rapid bedside identification of high-risk population in heart failure with reduced ejection fraction by acoustic cardiography Shang Wang, Fang Fang, Ming Liu, International Journal of Cardiology Heart FailureCardiovascular DiseaseCardiovascular ImagingRapid Bedside IdentificationCardiac Care	2013	22
A comparative study of Cardi‐O‐Fix septal occluder versus Amplatzer septal occluder in percutaneous closure of secundum atrial septal defects Türkay Sarıtaş, Mehmet Güngör Kaya, Yat Yin Lam, Catheterization and Cardiovascular Interventions	2011	19

Page 1